OverviewSuggest Edit

Bayer is a global life science company specializing in healthcare and nutrition. The company operates in three segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment engages in the development, production, and marketing of seeds, plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health, specialty therapeutics in the areas of oncology, hematology, and ophthalmology, as well as diagnostic imaging equipment and contrast agents. The Consumer Health segment offers nonprescription over-the-counter medicines, medical products, cosmetics and other self-care solutions in the categories of dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cough and cold.

TypePublic
Founded1863
HQLeverkusen, DE
Websitebayer.com

Latest Updates

Employees (est.) (Dec 2019)103,824
Job Openings2,204
Revenue (FY, 2019)€43.5 B(+11%)
Share Price (May 2020)€61 (-2%)

Key People/Management at Bayer

Werner Baumann

Werner Baumann

Chairman of the Board of Management, CEO
Liam Condon

Liam Condon

Member of the Board of Management, Crop Science
Wolfgang Nickl

Wolfgang Nickl

Member of the Board of Management, Finance
Stefan Oelrich

Stefan Oelrich

Member of the Board of Management, Pharmaceuticals
Heiko Schipper

Heiko Schipper

Member of the Board of Management, Consumer Health
Brett Begemann

Brett Begemann

Chief Operating Officer, Crop Science
Show more

Bayer Office Locations

Bayer has offices in Leverkusen, Bergkamen, Berlin, Bitterfeld-Wolfen and in 102 other locations
Leverkusen, DE (HQ)
Bayer Aktiengesellschaft, Kaiser-Wilhelm-Allee 1
Bergkamen, DE
Ernst-Schering-Straße 14
Berlin, DE
Müllerstraße 7
Bitterfeld-Wolfen, DE
Salegaster Chaussee 1
Burscheid, DE
Sträßchen 30
Frankfurt am Main, DE
Brüningstraße 50
Show all (107)

Bayer Financials and Metrics

Bayer Revenue

Embed Graph
View revenue for all periods
Bayer's revenue was reported to be €43.55 b in FY, 2019 which is a 10% increase from the previous period.
EUR

Revenue (FY, 2019)

43.5b

Revenue growth (FY, 2018 - FY, 2019), %

10%

Gross profit (FY, 2019)

26.1b

Gross profit margin (FY, 2019), %

59.9%

Net income (FY, 2019)

2.4b

EBIT (FY, 2019)

4.2b

Market capitalization (29-May-2020)

60.1b

Closing stock price (29-May-2020)

61.0

Cash (31-Dec-2019)

3.2b

EV

96.0b
Bayer's current market capitalization is €60.1 b.
Annual
EURFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

46.8b35.0b39.6b43.5b

Revenue growth, %

1%(25%)13%10%

Cost of goods sold

20.3b11.4b17.0b17.5b

Gross profit

26.5b23.6b22.6b26.1b
Quarterly
EURQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

11.9b11.8b11.3b13.2b12.2b8.0b9.1b9.5b9.9b13.0b11.5b9.8b

Cost of goods sold

5.1b5.0b4.8b5.3b5.1b2.6b2.9b3.5b4.5b5.3b4.4b3.7b

Gross profit

6.9b6.8b6.4b7.9b7.1b5.5b6.2b6.0b5.4b7.8b7.1b6.1b

Gross profit Margin, %

57%58%57%60%58%68%68%63%54%60%62%62%
Annual
EURFY, 2016FY, 2017FY, 2018FY, 2019

Cash

1.9b7.6b4.1b3.2b

Accounts Receivable

11.0b8.6b11.8b11.7b

Inventories

8.4b6.6b11.0b10.8b

Current Assets

30.4b30.1b30.9b32.6b
Quarterly
EURQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

3.6b1.1b1.2b2.2b2.8b5.6b5.3b5.0b4.9b4.1b3.3b4.4b

Accounts Receivable

11.6b11.8b10.8b13.0b12.1b8.8b9.5b14.3b11.7b14.3b14.2b11.9b

Inventories

8.5b8.3b8.4b8.7b8.5b6.7b6.4b11.1b11.1b10.7b10.4b10.5b

Current Assets

26.7b24.7b25.2b33.4b32.7b30.8b33.2b37.8b32.1b32.7b32.8b33.5b
Annual
EURFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

4.5b7.3b1.7b2.4b

Depreciation and Amortization

3.7b2.7b6.4b5.4b

Inventories

(3.0m)(293.0m)615.0m(103.0m)

Accounts Payable

452.0m265.0m(44.0m)759.0m
EURY, 2019

EV/EBIT

22.9 x

EV/CFO

11.7 x

Revenue/Employee

403.2k

Debt/Equity

0.8 x

Debt/Assets

0.3 x

Financial Leverage

2.7 x

P/E Ratio

24.8
Show all financial metrics

Bayer Operating Metrics

FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Countries

147 151 152 148 153

Suppliers

112 k112.50 k110.90 k93.33 k101.19 k86.40 k

Patent Applications

68.20 k66.70 k50.80 k48.10 k

Patents Issued

8.30 k7.20 k5 k4.70 k
Show all operating metrics

Bayer Acquisitions / Subsidiaries

Company NameDateDeal Size
BlueRock TherapeuticsAugust 08, 2019$1 b
Monsanto CompanyMay 23, 2016$62.50 b
Zoner.agFebruary 15, 2015
Dihon PharmaceuticalNovember 05, 2014€460 m
Merck-Consumer Care (MCC)October 01, 2014$14.20 b
AlgetaDecember 19, 2013$2.90 b
AgraQuest, Inc.July 01, 2012$425 m
Artificial Muscle IncMarch 11, 2010
Icon GeneticsFebruary 13, 2006
ZeptosensMarch 09, 2005
Show more

Bayer Revenue Breakdown

Embed Graph

Bayer revenue breakdown by business segment: 12.5% from Consumer Health, 41.2% from Pharmaceuticals, 45.5% from CropScience and 0.7% from Other

Bayer revenue breakdown by geographic segment: 15.3% from Latin America, 19.8% from Asia / Pacific, 34.6% from North America and 30.3% from Europe / Middle East / Africa

Human Capital Metrics

Bayer's employees are reported to be approximately 40% female and 60% male.
Embed Graph
Show all human capital metrics

Bayer Online and Social Media Presence

Embed Graph

Bayer News and Updates

VeChain to Develop Drug-Tracing Platform for Pharma Giant Bayer

Bayer China is tapping VeChain to help it track clinical trial drugs along the blockchain.

Bayer to support Harvard Research Study to Evaluate Trust in Science, Including in COVID-19 pandemic

Leverkusen / Cambridge, Mass., May 26, 2020 – With the public debate on the merits of scientific data throughout the COVID-19 pandemic, Bayer today announced its support for a new, multi-year Harvard Data Science Initiative (HDSI) research effort. This initiative will explore the public engagement w…

NewsWatch: Bayer, Lufthansa drive gains in Europe amid holiday-thinned trading

European stocks rose to kick off the week on Monday, albeit with the action thinned by holidays in the U.K. and the U.S.

UPDATE 1-European shares rise on recovery hopes, Bayer jumps

* Lagardere jumps as LVMH's Arnault to buy stake (Adds comment, updates prices)

European shares rise in thin trading, Bayer jumps

European shares rose in thin trading on Monday, as optimism over reopening of countries and signs of more stimulus for the battered euro zone economy helped sentiment.

Bayer reaches verbal deal to settle up to 85,000 Roundup cancer lawsuits

The company inherited the litigation when it bought Monsanto in 20178.
Show more

Bayer Blogs

Nubeqa® (darolutamide) receives EU approval as a new treatment for men with non-metastatic castration-resistant prostate cancer (for specialized target groups only)

Oral androgen receptor inhibitor (ARi) Nubeqa® (darolutamide) approved for the treatment of men with non-metastatic castration-resistant prostate cancer (nmCRPC), who are at high risk of developing metastatic disease / Approval is based on Phase III ARAMIS trial results showing a statistically signi…

Bayer planning to hold online-only stockholders’ meeting on April 28, 2020

Stockholders able to exercise right to submit questions and cast votes in a timely manner / Online stockholders’ meeting enables proposed dividend of 2.80 euros per share for 2019 to be paid on time and in full / Baumann: “Reliability for our stockholders is very important, especially during the cri…
Show more

Bayer Frequently Asked Questions

  • When was Bayer founded?

    Bayer was founded in 1863.

  • Who are Bayer key executives?

    Bayer's key executives are Werner Baumann, Liam Condon and Wolfgang Nickl.

  • How many employees does Bayer have?

    Bayer has 103,824 employees.

  • What is Bayer revenue?

    Latest Bayer annual revenue is €43.5 b.

  • What is Bayer revenue per employee?

    Latest Bayer revenue per employee is €419.4 k.

  • Who are Bayer competitors?

    Competitors of Bayer include AstraZeneca, Roche and Novartis.

  • Where is Bayer headquarters?

    Bayer headquarters is located at Bayer Aktiengesellschaft, Kaiser-Wilhelm-Allee 1, Leverkusen.

  • Where are Bayer offices?

    Bayer has offices in Leverkusen, Bergkamen, Berlin, Bitterfeld-Wolfen and in 102 other locations.

  • How many offices does Bayer have?

    Bayer has 107 offices.